Colgate-Palmolive Stock Slips 0.71% as $580M Trading Volume Ranks 210th Amid Strategic Shifts
Colgate-Palmolive (NYSE:CL) closed at a 0.71% decline on October 6, 2025, with a trading volume of $580 million ranking 210th among U.S. equities. The stock's performance coincided with strategic updates regarding its product portfolio and market positioning. Recent announcements highlighted a shift in resource allocation toward oral care innovations, while cost optimization measures across manufacturing operations were reiterated in investor communications.
Analysts noted the stock's sensitivity to investor sentiment shifts as it approaches key earnings thresholds. The company's decision to phase out underperforming skincare lines in select markets has sparked mixed reactions, with some observers viewing the move as a necessary streamlining of operations. Concurrently, the firm reaffirmed its commitment to maintaining dividend stability despite navigating inflationary pressures in raw material procurement.
To run this back-test robustly I need to pin down a few implementation details that aren’t fully defined yet: 1. Universe • Should I consider all U.S. common stocks (NYSE + NASDAQ + AMEX), or a narrower universe (e.g., only S&P 500 constituents, or only stocks above a certain price)? 2. Ranking timestamp • Do you want to rank the stocks by the same day’s trading-volume and buy at that day’s close, then sell at the next day’s close? (That’s the usual one-day “hold” convention.) 3. Weighting & capital allocation • Equal-weight each of the 500 names each day, rebalancing completely every day? 4. Frictions • Any assumptions for transaction costs/slippage you’d like me to include (e.g., 1 bp per trade)? 5. Survivorship bias • Are you comfortable with using today’s list of tickers and applying it back in time (quick but introduces bias), or should we include delisted symbols for accuracy? Once I have these points confirmed I can generate the daily trading signals and run the portfolio-level back-test from 2022-01-03 through 2025-10-06.


Comentarios
Aún no hay comentarios